Referrals for CLTI: Qualitative Study

The Experiences of Patients With Chronic Limb-threatening Ischaemia From First Symptom to Vascular Surgery Assessment: a Qualitative Study

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT05659004

Enrollment

Registered

2022-12-21

Start date

2023-01-10

Completion date

2023-07-07

Last updated

2023-08-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Limb Threatening Ischemia

Brief summary

The goal of this qualitative study is to explore the experiences of patients who have been diagnosed with chronic limb-threatening ischaemia (CLTI). The main questions it aims to answer are: * What are the perceptions and experiences of patients between first symptom of CLTI and vascular surgery assessment * What is important to patients during this process. Participants will be interviewed and their words analysed using reflexive thematic analysis.

Detailed description

There are delays at every stage of the patient journey from developing chronic limb-threatening ischaemia (CLTI) to treatment, associated with poorer outcomes for patients. There is currently limited national and international guidance on how and when to refer patients with suspected CLTI to specialist vascular surgery services. The use of qualitative interviews will allow us explore perceptions and experiences of patients with CLTI being referred to vascular surgery services, and identify possible ways to improve the process via interviews. This study will provide novel information on patient experience, and together with other work provide a framework for improvement of the referral process for CLTI.

Interventions

BEHAVIORALQualitative interview

No intervention

Study design

Observational model

OTHER

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to 120 Years

Healthy volunteers

Inclusion criteria

\- CLTI diagnosed in the last year

Exclusion criteria

* Lacking capacity to consent to interview * Potential to be violent * Cognitive impairment * Non-English speaking

Design outcomes

Primary

Measure	Time frame	Description
Experiences and perceptions of patients on their journey to diagnosis of CLTI	To be conducted in 2023	Exploring patient experience

Secondary

Measure	Time frame	Description
Potential improvements the process from first symptom to diagnosis of CLTI	To be conducted in 2023	Identifying targets for improvement work

Countries

United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026